← 產業報告目錄
Psychiatric Digital Biomarkers Market, Share & Trends Analysis Report, By Type (Wearable, Mobile based Applications, Sensors), Clinical Practice (Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive and Prognostic Psychiatric Digital Biomarkers), End Use, By Region, and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-25頁數 170報告編號 INSIGHTACE-7809e4fb9f
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Psychiatric Digital Biomarkers Market on a global scale was estimated at USD 513.3 Mn in 2023 and is poised to attain USD 2,879.7 Mn by 2031, with a projected CAGR of 24.7% between 2024 and 2031.
At its core, Psychiatric Digital Biomarkers pertains to The global market for psychiatric digital biomarkers focuses on the creation, application, and utilization of digital technologies designed to measure and analyze physiological and behavioral data for. Stakeholders across the healthcare landscape are surgingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and surging investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Psychiatric Digital Biomarkers Market Snapshot
Chapter 4. Global Psychiatric Digital Biomarkers Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Wearable
5.2.2. Mobile based Applications
5.2.3. Sensors
5.2.4. Others
Chapter 6. Market Segmentation 2: Clinical Practice Estimates & Trend Analysis
6.1. Clinical Practice & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Clinical Practice:
6.2.1. Diagnostic Psychiatric Digital Biomarkers
6.2.2. Monitoring Psychiatric Digital Biomarkers
6.2.3. Predictive and Prognostic Psychiatric Digital Biomarkers
6.2.4. Other's
Chapter 7. Market Segmentation 3: by End Use Estimates & Trend Analysis
7.1. by End Use & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End Use:
7.2.1. Healthcare companies
7.2.2. Healthcare Providers
7.2.3. Payers
7.2.4. Others
Chapter 8. Psychiatric Digital Biomarkers Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.1.2. North America Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts Clinical Practice, 2024-2031
8.1.3. North America Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2024-2031
8.1.4. North America Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.2.2. Europe Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts Clinical Practice, 2024-2031
8.2.3. Europe Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2024-2031
8.2.4. Europe Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.3.2. Asia Pacific Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts Clinical Practice, 2024-2031
8.3.3. Asia-Pacific Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2024-2031
8.3.4. Asia Pacific Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.4.2. Latin America Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts Clinical Practice, 2024-2031
8.4.3. Latin America Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2024-2031
8.4.4. Latin America Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.5.2. Middle East & Africa Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts Clinical Practice, 2024-2031
8.5.3. Middle East & Africa Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2024-2031
8.5.4. Middle East & Africa Psychiatric Digital Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Koneksa
9.2.2. Biogen Inc.
9.2.3. BioSensics
9.2.4. Empatica Inc.
9.2.5. Vivo Sense
9.2.6. IXICO plc
9.2.7. Huma
9.2.8. kintsugi health
9.2.9. Sonde Health, Inc.
9.2.10. Clario
9.2.11. iMediSync
9.2.12. BEATS Medical
9.2.13. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們